Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. It is valued for its role in enhancing binding affinity and selectivity in drug molecules targeting tyrosine kinases. Commonly employed in research and development of small-molecule therapeutics for oncology and inflammatory diseases. Its structure supports the design of potent, orally bioavailable compounds with improved metabolic stability.